NCT05611281View on ClinicalTrials.gov

GS3-007a Oral Solution in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

September 22, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Healthy Subject
Interventions
DRUG

GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication

The dosage was calculated according to body weight and dose group once a day according to the assigned group.

Trial Locations (1)

610000

Chengdu Xinhua Hospital Affiliated to North Sichuan Medical College, Chengdu

All Listed Sponsors
lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY